Dysfunction of Synaptic Vesicle Endocytosis in Parkinson’s Disease
Parkinson’s disease (PD) is the second most common neurodegenerative disorder after Alzheimer’s disease. It is a chronic and progressive disorder estimated to affect at least 4 million people worldwide. Although the etiology of PD remains unclear, it has been found that the dysfunction of synaptic v...
Main Authors: | Li Zou, Ye Tian, Zhentao Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-05-01
|
Series: | Frontiers in Integrative Neuroscience |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fnint.2021.619160/full |
Similar Items
-
From Synaptic Dysfunction to Neuroprotective Strategies in Genetic Parkinson’s Disease: Lessons From LRRK2
by: Andrea Mancini, et al.
Published: (2020-07-01) -
The Effect of Aggregated Alpha Synuclein on Synaptic and Axonal Proteins in Parkinson’s Disease—A Systematic Review
by: Jennifer Murphy, et al.
Published: (2022-08-01) -
Are Therapies That Target α-Synuclein Effective at Halting Parkinson’s Disease Progression? A Systematic Review
by: Abbie T. Rodger, et al.
Published: (2023-07-01) -
From Synaptic Protein to Prion: The Long and Controversial Journey of α-Synuclein
by: Antonio Heras-Garvin, et al.
Published: (2020-09-01) -
Silica Nanoparticles Promote α-Synuclein Aggregation and Parkinson’s Disease Pathology
by: Xin Yuan, et al.
Published: (2022-01-01)